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Multiple domains of cognition are impaired. According to previous studies, the most affected areas of cognition are: Performances on the cognitive tests for the intelligence quotient (IQ), executive function, processing speed, working memory, verbal memory, and attention. [3, 4] Most magnetic resonance (MR) studies have been focused on the assessment of MS plaques and their correlation with neurological disability. [5] Several studies have shown that a greater lesion burden and brain atrophy occur in MS patients with a more severe cognitive impairment. [6] [7] [8] [9] In recent times, measures of RNFL by optical coherence tomography (OCT) were seen to be a potentially reliable predictor outcome in MS. [10, 11] Some studies have demonstrated a correlation between optical nerve atrophy measured by RNFL and the degree of brain atrophy in patients with MS. [12] Taking into account the correlation between cognitive impairment and brain atrophy and the correlation between brain atrophy and optical nerve atrophy, it is reasonable to hypothesize a correlation between cognitive decline and optical nerve atrophy, measured by OCT.
To better understand both the benefits and limitations of measuring RNFL and to define its place in the often complicated array of neurological symptoms in MS patients, further studies are needed.
Therefore, the aim of our cross-sectional study was to analyze the relationship between the thickness of the RNFL and intellectual impairment and MRI findings, including lesion load and brain atrophy.
In fact, a correlation between optical nerve atrophy measured by OCT and cognitive impairment was seen in patients with MS. [13] However, this study and some similar studies, mentioned in the article, did not evaluate the correlation of these three parameter (RNFL, MRI findings, and WAIS scores). We want to determine a new tool for assessment of patients with cognitive problems and a more reliable discrimination between individuals with and without axonal loss.
MATERIALS AND METHODS
A cross-sectional study was conducted at the University Hospital of Kashani, Isfahan, Iran, from September to December 2013. Patients were recruited from the MS Outpatient Clinic in the Kashani Hospital. The present study was approved by the Ethical Committee of the Isfahan University of Medical Sciences and informed consent was obtained from each participant.
Inclusion criteria for the study were, definite MS according to the McDonald Criteria [14] for MS, irrespective of the disease subtype and disease duration and drug types. Patients have not acute relapse during the past three months.
Patients with ophthalmic diseases that might impair or bias the OCT (e.g., diabetes, glaucoma, congenital abnormal optic disc, such as tilted nerve, myopia ≥ 4 diopters, and hypermetropia ≥ 4 diopters) and patients who could not undergo MRI, such as, those with pacemakers or claustrophobia, were excluded. We also excluded patients with a past history of serious head trauma and with major psychiatric disorders that may have an effect on the WAIS-R result. In this study, patients with a previous history of bilateral optic neuritis were excluded.
The intelligence was evaluated by a trained psychologist, using the WAIS-R, a revised form of the WAIS, which was considerably extended from the previous edition that was released in1981. It consisted of six verbal and five performance subtests. [15] In this study, a verbal IQ, performance IQ, and full scale IQ were obtained. Moreover, an association among the digit symbol subtest, vocabulary subtest, object assembly subtest, and digit symbol subtest (most affected domain in MS patients), with other parameters, were studied. In all the patients, the following variables were collected: Age, sex, other underlying disease, duration of MS, the course of MS, previous history of optic neuritis, and severity of the disease according to the Expanded Disability Status Scale Score (EDSS).
Optical coherence tomography was performed on both eyes of each patient, using a Stratus OCT 3000 (Carl Zeiss Meditec, Inc., Dublin, CA, USA), by experienced operators. Retinal nerve fiber layer thickness (RNFL) was measured using the standard protocol with three 3.4 mm circular scans. A technician, who was blind to the results of the neuropsychological studies, made the measurements. The average RNFL thickness in the macula and optic nerve was obtained in micrometers.
For all patients, brain MRIs were obtained in a single session, using the 1.5 T MRI. For every patient, the T1, T2, Fluid-attenuated inversion recovery (FLAIR), and proton density sequences in the axial and sagittal planes were obtained. The MRI scan was visually assessed by a single observer, unaware of the subject's identity. A lesion was defined as a region of prolonged T2 relaxation time with a diameter greater than 3 mm. [16] Only the supratentorial brain was considered for classification purposes. Parenchymal atrophy was defined on the basis of the appearance of cortical sulci, ventricular size, and corpus callosum thickness on the axial and sagittal Tl-weighted images. For the purposes of our investigation, the MRI images of the supratentorial brain were divided into four groups according to the following arbitrary criteria: The MRI scans were scored by an experienced neurologist, who was blind to the OCT and neuropsychological data. A maximum of three months elapsed between the MRI examinations and the neuropsychological tests.
Statistical analysis
The correlation between the RNFL thickness, WAIS-R measures, and other clinical variables was carried out using a bivariate correlation (Pearson correlation.). Statistical analysis was done by utilizing the SPSS 20.0. A P value ≤ 0.05 was considered the threshold of statistical significance. For the statistical analysis, one eye from every patient was chosen, such that, the eyes with optic neuritis were avoided.
There are reports of a reliability coefficient of 0.76 to 0.94 and a validity coefficient of 0.75 for WAIS-R, in the Iranian population. WAIS-R was widely supported for use in our patients, in the clinical context. [17] 
RESULTS
One hundred multiple sclerosis patients were included in this study, 82 females and 18 males. The mean age was 33.5 ± 9.0 years (minimum 19 and maximum 60 years). The mean EDSS score of the patients with MS was 2.05 ± 1.1 (range 1-6). The mean EDSS score of patients with MS was 2.05 ± 1.1 (range 1-6). The demographical and clinical data of patients in each MRI group are shown in Table 1 . The thickness of the RNFL was measured in each eye using OCT. The average RNFL thickness in the macula and optic nerve were obtained in micrometers.
In Table 3 , the RNFL thicknesses of the optic nerve and macula in patients with multiple sclerosis in the four groups are shown. According to this Table, the average RNFL thickness of the macula (µm), the RNFL thickness of the optic nerve head (µm), and the total volume of macula (mm 3 ) had no significant correlation with the MRI findings.
We examined the correlation of the RNFL thickness of the macula and the head of optic nerve, assessed with OCT and WAIS-R scores. Table 4 shows these correlations. According to this Table, there was a significant correlation between the average RNFL thickness of the macula and verbal IQ (P value = 0.01) and full IQ (P value = 0.01).
DISCUSSION
Recognition of new tools for MS evaluation is crucial to improve our ability to predict disease evolution and for monitoring of responses to therapy. [18] The goal of our study was to search for correlations between the RNFL thickness of the macula and head of the optic nerve and the MRI findings, with WAIS-R scores in patients with multiple sclerosis.
In this study, there was significant correlation between the average RNFL thickness of the macula (µm) and total volume of the macula (mm 3 ), with verbal IQ and full IQ. There was no significant correlation between the RNFL layer in the head of the optic nerve and MRI findings (lesion load and brain atrophy) in MS patients. There was a near-significant correlation between the RNFL in the center of the macula and the MRI findings (P = 0.06) toward the lower RNFL, in patients with evidence of parenchymal atrophy (Group 4). Patients with brain atrophy (Group 4) had a lower verbal IQ than patients without brain atrophy and lower lesion load (P value = 0.01). Also there was near-significant correlation between the full IQ and brain atrophy (Group 4) with P value = 0.051.
The relationship between brain atrophy measured with MRI and cognitive impairment is well-established in patients with MS. [19] In this study, we have also found a correlation between brain atrophy and verbal IQ and near-significant correlation between brain atrophy and full IQ. In a new study by Ryann, in 2012, it has been found that MS patients had significantly lower subtest and composite scores, with the help of WAIS, for evaluation of IQ. The patients' mean scores were consistently in the low-average to average range, and the patterns of performance across the groups did not differ significantly, although there was a trend toward higher scores on the Verbal Comprehension Index and lower scores on the Processing Speed Index. Approximately 78% of the patients had actual Full Scale IQs that were significantly lower than the pre-illness, demographically-based IQ estimates. [4] In other studies also, it was concluded that the central and whole brain atrophy accounted for more variance in MS cognition than in the lesion burden. [20, 21] Our findings demonstrated lower IQ (full and verbal) in patients with brain atrophy.
In another study, it was seen that global IQ seemed not to be impaired on baseline and over time; consequently they analyzed the patients' performances of each WAIS subtest to better clarify the individual differences. Overall, most verbal performance WAIS subtests (comprehension, arithmetic, vocabulary, and digit span) showed mild worsening in an increased number of patients after the follow-up period. This may be indicative of impairments in information processing, activation to recall, and organizing the right response for word meaning and problem solving. [22] In our study also, patients with brain atrophy had a lower verbal IQ. However, full IQ had only a near significance correlation with brain atrophy.
The size of the corpus callosum appears to be relevant to cognition in people with MS. In fact, atrophy of the whole corpus callosum predicted test performance on measures of mental processing speed, and rapid problem-solving, whereas, atrophy of the anterior callosum strongly affected the performance on the verbal fluency task. [23] In our study, we have found a near-significant correlation between RNFL and brain atrophy in MRI. Data regarding the relation between OCT parameters and MRI measures for neurodegeneration are not yet consistent and a consensus on the most relevant parameter has yet to be reached. [24, 25] However, a similar finding on correlation MRI atrophy and RNFL thickness is shown in another study. [26] We have also evaluated the relationship between RNFL thickness and the scores of the WAIS-R test. We found average RNFL thickness of the macula and the total volume of the macula had a significant correlation with verbal IQ and full IQ.
The OCT is a noninvasive, easy-to-perform, inexpensive procedure that has been correlated with brain atrophy detected by MRI in multiple sclerosis patients, [27, 28] indicating its ability to detect brain abnormalities. Although we did not find any significant correlation between the lesion load and brain atrophy with RNFL layer thickness in our patients, there was a relationship between the WAIS-R scores and RNFL layer thickness.
Imaging of the optic pathway and RNFL is a new promising strategy to assess axonal loss in MS, as the visual pathway is frequently involved in this disease and retinal axons have no myelin sheath. [28, 29] Other studies reported that many patients with MS and even clinically isolated syndrome (CIS) had a lower RNFL thickness compared to the control healthy group, [30, 31] suggesting that this method may be an effective biomarker of global axonal loss, and does not only reflect the changes caused by optic neuritis. [28] On the other hand, it has been shown that OCT correlates with cognition in patients with MS. [32, 33] We found a significant correlation between the average RNFL thickness of the macula and total volume of the macula with verbal IQ and full IQ. However, the optic nerve head RNFL thickness only had significant correlation with the vocabulary subtest and had no significant correlation with the other intelligence parameters. Thus, our results suggest that the RNFL measurements, especially average RNFL thickness at the macula, are able to identify tissue changes associated with cognitive and intelligence impairment.
Some studies demonstrated significant severe axonal loss at the temporal quadrants. [34, 35] However, in our studies, like some other studies, [8, 33] we did not find preferential involvement in the superior or inferior quadrant.
Our study has some clear limitations. There are no detailed data comparing the ophthalmological and neuropsychological evaluations between patients and the healthy group of controls, therefore, it could be argued that decreased visual acuity or other parameters influenced the performance in cognitive tests among patients.
In this study we have evaluated the cognition of patients with WAIS-R; it would have been better if we done some additional tests like PASAT) paced auditory serial addition test) 2 and 3 seconds for evaluation of cognition changes in MS patients, but unfortunately these tests were not validated for use in Iranian patients. In our center a new MRI method, such as, the volumetric MRI was not available, so we used the traditional MRI method.
CONCLUSION
The RNFL thickness had significant correlation with some domains of intelligence that was most affected in multiple sclerosis patients. Therefore, the OCT technique can be used for evaluation and monitoring of MS patients with cognition and intelligence problems.
